HomeAI · summaries
Storia in 2 fonti
Dabur India shares in focus after US FDA places drugs from Silvassa plant under import alert. Here’s why
Dabur India shares are set to be in focus after the US FDA issued an import alert on drugs manufactured at its Silvassa plant, citing data integrity lapses. The company said the impact is limited to a small portion of operations, while broader business and domestic sales remain unaffected.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
economictimes.indiatimes.com
US drug regulator issues import alert for drugs made at a Dabur India plant
The US Food and Drug Administration has placed Dabur India's factory on an import alert. This action follows an inspection that revealed significant issues with data integrity and…
- ·
Dabur India shares in focus after US FDA places drugs from Silvassa plant under import alert. Here’s why
Dabur India shares are set to be in focus after the US FDA issued an import alert on drugs manufactured at its Silvassa plant, citing data integrity lapses. The company said the…
- ·
thehindubusinessline.com
Dabur shares steady, USFDA issues import alert for Silvassa facility
Dabur India shares remained in focus on Friday after the company said the US Food and Drug Administration (FDA) issued Import Alert 66-40 for its Silvassa manufacturing facility.